What is Scitara?
Scitara operates as a global provider of lab-specific integration Platform as a Service (iPaaS) solutions. Their cloud-based platform, DLX, is engineered to connect laboratory instruments, automate complex data workflows, and meticulously monitor digital transactions. This comprehensive offering primarily serves research and development, bioprocessing, and quality control laboratories within process-based industries. By focusing on the critical movement and integration of data, Scitara aims to accelerate scientific discovery, optimize production efficiency, and ensure adherence to stringent compliance standards, positioning itself as a key enabler of digital transformation in the life sciences sector.
How much funding has Scitara raised?
Scitara has raised a total of $25M across 3 funding rounds:
Series A
$5M
Series B
$15M
Debt
$5M
Series A (2021): $5M with participation from Flybridge Capital Partners and Northpond Ventures LLC
Series B (2022): $15M led by Flybridge Capital Partners and Northpond Ventures
Debt (2026): $5M, investors not publicly disclosed
Key Investors in Scitara
Flybridge Capital Partners
Flybridge Capital Partners is an early-stage venture capital fund with extensive experience, focusing on AI-native startups. They are known for their hands-on approach, supporting companies from pre-seed to seed stages, particularly in vertical SaaS, data infrastructure, and AI-enabled applications.
Northpond Ventures
Northpond Ventures is an investment firm that has participated in Scitara's funding rounds. While specific domain details are not provided, their involvement suggests a focus on technology and scientific innovation.
What's next for Scitara?
The recent major strategic investment signifies Scitara's readiness for accelerated scaling and market expansion. With a focus on enterprise-level solutions, the company is poised to further enhance its DLX platform, potentially expanding its reach into new scientific domains or deepening its capabilities in existing ones. Future developments are likely to concentrate on strengthening its iPaaS offerings, integrating advanced analytics, and forging strategic partnerships to solidify its position as a leader in laboratory integration and data management. This capital infusion will be instrumental in driving innovation and supporting the growing demand for robust, compliant, and efficient scientific workflows.
See full Scitara company page
